Literature DB >> 22820980

The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.

Teresa M Darragh1, Terence J Colgan, J Thomas Cox, Debra S Heller, Michael R Henry, Ronald D Luff, Timothy McCalmont, Ritu Nayar, Joel M Palefsky, Mark H Stoler, Edward J Wilkinson, Richard J Zaino, David C Wilbur.   

Abstract

The terminology for human papillomavirus (HPV)-associated squamous lesions of the lower anogenital tract has a long history marked by disparate diagnostic terms derived from multiple specialties. It often does not reflect current knowledge of HPV biology and pathogenesis. A consensus process was convened to recommend terminology unified across lower anogenital sites. The goal was to create a histopathologic nomenclature system that reflects current knowledge of HPV biology, optimally uses available biomarkers, and facilitates clear communication across different medical specialties. The Lower Anogenital Squamous Terminology (LAST) Project was cosponsored by the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology and included 5 working groups; 3 work groups performed comprehensive literature reviews and developed draft recommendations. Another work group provided the historical background and the fifth will continue to foster implementation of the LAST recommendations. After an open comment period, the draft recommendations were presented at a consensus conference attended by LAST work group members, advisors, and representatives from 35 stakeholder organizations including professional societies and government agencies. Recommendations were finalized and voted on at the consensus meeting. The final, approved recommendations standardize biologically relevant histopathologic terminology for HPV-associated squamous intraepithelial lesions and superficially invasive squamous carcinomas across all lower anogenital tract sites and detail the appropriate use of specific biomarkers to clarify histologic interpretations and enhance diagnostic accuracy. A plan for disseminating and monitoring recommendation implementation in the practicing community was also developed. The implemented recommendations will facilitate communication between pathologists and their clinical colleagues and improve accuracy of histologic diagnosis with the ultimate goal of providing optimal patient care.

Entities:  

Mesh:

Year:  2012        PMID: 22820980     DOI: 10.1097/LGT.0b013e31825c31dd

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  106 in total

1.  A Suggested Approach to Simplify and Improve Cervical Screening in the United States.

Authors:  Mark Schiffman; Nicolas Wentzensen
Journal:  J Low Genit Tract Dis       Date:  2016-01       Impact factor: 1.925

2.  [Epidemiology, prevention and early detection of cervical cancer].

Authors:  Nicolas Wentzensen
Journal:  Onkologe (Berl)       Date:  2016-08-04       Impact factor: 0.234

3.  Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa.

Authors:  Bridgette J Goeieman; Cynthia S Firnhaber; Eefje Jong; Pam Michelow; Patricia Kegorilwe; Avril Swarts; Anna-Lise Williamson; Bruce Allan; Jennifer S Smith; Timothy J Wilkin
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

Review 4.  A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.

Authors:  Michelle J Khan; L Stewart Massad; Walter Kinney; Michael A Gold; E J Mayeaux; Teresa M Darragh; Philip E Castle; David Chelmow; Herschel W Lawson; Warner K Huh
Journal:  Gynecol Oncol       Date:  2016-02-22       Impact factor: 5.482

5.  Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.

Authors:  Philip E Castle; Walter K Kinney; Xiaonan Xue; Li C Cheung; Julia C Gage; Nancy E Poitras; Thomas S Lorey; Hormuzd A Katki; Nicolas Wentzensen; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

6.  Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).

Authors:  Carmen Hidalgo-Tenorio; Jessica Ramírez-Taboada; Concepción Gil-Anguita; Javier Esquivias; Mohamed Omar-Mohamed-Balgahata; Antonio SamPedro; Miguel Lopez-Ruz; Juan Pasquau
Journal:  AIDS Res Ther       Date:  2017-07-18       Impact factor: 2.250

7.  Incidence of cervical precancers among HIV-seropositive women.

Authors:  L Stewart Massad; Xianhong Xie; Gypsyamber D'Souza; Teresa M Darragh; Howard Minkoff; Rodney Wright; Christine Colie; Lorraine Sanchez-Keeland; Howard D Strickler
Journal:  Am J Obstet Gynecol       Date:  2014-12-10       Impact factor: 8.661

8.  Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.

Authors:  George Kurdgelashvili; Graça M Dores; Samer A Srour; Anil K Chaturvedi; Mark M Huycke; Susan S Devesa
Journal:  Cancer       Date:  2013-04-11       Impact factor: 6.860

9.  Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.

Authors:  Shao-Ming Wang; Danny Colombara; Ju-Fang Shi; Fang-Hui Zhao; Jing Li; Feng Chen; Wen Chen; Shu-Min Li; Xun Zhang; Qin-Jing Pan; Jerome L Belinson; Jennifer S Smith; You-Lin Qiao
Journal:  Int J Gynecol Cancer       Date:  2013-05       Impact factor: 3.437

10.  Cervical histopathology variability among laboratories: a population-based statewide investigation.

Authors:  Julia C Gage; Mark Schiffman; William C Hunt; Nancy Joste; Arpita Ghosh; Nicolas Wentzensen; Cosette M Wheeler
Journal:  Am J Clin Pathol       Date:  2013-03       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.